Document Classification

Section Type: RESULTS

Text: Twelve weeks of etanercept treatment induced a significant increase in the number of interferon gamma (IFNgamma) positive (14. 2 % (9. 6-19. 5 %) before v 24. 4 % (13. 4-36. 4 %) after) and TNFalpha positive CD4 + T cells (p = 0. 008 for both cytokines) and IFNgamma positive (37. 5 % (19. 0-45. 4 %) before v 52. 9 % (33. 2-60. 0 %) after) and TNFalpha positive CD8 + T cells (p = 0. 008 for both cytokines) upon phorbol myristate acetate/ionomycin stimulation, but not in the placebo group.